Melperone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09224 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 16 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hereditary late onset Parkinson disease | KG + DL |
| 2 | headache disorder | KG + DL |
| 3 | trigeminal autonomic cephalalgia | KG + DL |
| 4 | juvenile onset Parkinson disease 19A | KG + DL |
| 5 | atypical juvenile parkinsonism | KG + DL |
| 6 | migraine disorder | KG + DL |
| 7 | X-linked parkinsonism-spasticity syndrome | KG + DL |
| 8 | migraine with brainstem aura | KG + DL |
| 9 | open-angle glaucoma | KG + DL |
| 10 | multiple system atrophy | KG + DL |
| 11 | primary hereditary glaucoma | KG + DL |
| 12 | acute intermittent porphyria | KG + DL |
| 13 | parkinsonian-pyramidal syndrome | KG + DL |
| 14 | common cold | KG + DL |
| 15 | myelitis | KG + DL |
| 16 | gastroduodenitis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.